Constipation Laxative Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2030

Published on : May-2020 | List of Tables : 32 | List of Figures : 205 | No. of Pages : 170 | Report Code : FACT4801MR |

Global Constipation-Laxative Market Overview:

The global constipation laxative market is set to witness steady growth, expanding at a CAGR of 5.7% during the forecast period (2020-2030). The market is set to reach a value pool of US$ 10.8 Bn through 2030. Opioid Induced Constipation (OIC) is the most prevalent side-effect post consumption of a certain class of drugs and may negatively impact patients’ adherence to analgesic prescriptions. OIC accounts for six out of ten non-cancer patients receiving opioids.

In addition, various metabolic disorders are also responsible for constipation. Diabetics are two times more susceptible to constipation than non-diabetic patients. Based on the aforementioned factors, the use of constipation laxatives has soared and will continue to find enhanced growth prospects in the future.

Global Constipation-Laxative Market Analysis by Mode of Mechanism

Bulk-forming laxatives are anticipated to capture the maximum market share, accounting for over one-third of the global constipation laxatives market throughout the forecast period. At the same time, the stimulants segment is poised to expand the fastest at a CAGR of 6.0%.

Ease of ingestion and gradual improvement of symptoms are the main factors behind increased preference for bulk-forming laxatives. Additionally, these laxatives also prevent the occurrence of explosive diarrhea, a common side-effect of stimulant laxatives. Bulk-forming laxatives also improve medical conditions such as hemorrhoids, anal fissures and hernia. Increased usage of stimulant-based laxatives is attributed to its immediate effectiveness, especially suppositories which work in as little as half-an-hour.

global constipation laxative market highlights

For answers to all the possible questions required for gauging the performance of the constipation-laxative market, get in touch with our expert analyst.

Global Constipation Laxative Market: Regional Insights:

North America and Europe collectively, shall account for over three-fifth of the global constipation-laxative market during the forecast period. While North America is poised to expand at a CAGR of ~5.5%, Europe shall expand at ~6.0%.

Increasing prevalence of constipation, growing awareness about gastrointestinal infections and increased support from the government to develop adequate healthcare infrastructure are some important factors driving market growth of constipation laxatives in North America and Europe.

Global Constipation Laxative Market Manufacturers

The global constipation-laxative market is consolidated. Prominent market players dominating the market include: GlaxoSmithKline, Bayer AG, Sanofi, Takeda, Abbott Laboratories and Purdue Pharma LP. The top five key players accounted for approximately 57.8% revenue share in 2019, while the remaining players accounted for over 40% of the revenue. Manufacturers are concentrating on research and development to launch new branded generic products to create incremental dollar opportunities by targeting emerging economies.

Some market players are also resorting to online sales platforms for marketing over-the-counter laxative brands. Less prominent players are concentrating on mergers and acquisitions in order to establish market presence. For instance, in 2018, Mallinckrodt Pharmaceuticals acquired Sucampo Pharmaceuticals to leverage their industry leading capabilities and R&D capabilities to accelerate innovation.

constipation laxative market forecast trend analysis

Access our latest COVID-19 impact insights on the constipation laxative market by requesting for a report sample here

COVID-19’s Impact on Constipation Laxatives Market:

The coronavirus outbreak is a human tragedy, affecting millions of people worldwide. Even today, COVID-19 is continuously expanding its tentacles, paralyzing all economic activity and hindering production capabilities. The International Monetary Fund has estimated that global growth is anticipated to fall by 3% throughout the remainder of 2020. Additionally, cost of raw materials to manufacture important drugs has augmented. Based on these trends, it is prudent to conclude that the world is headed towards a massive recession in the coming months.

Fortunately, the impact of COVID-19 on the constipation-laxatives market has been minimal. The laxative market is flooded with different brands from leading as well as mid-sized manufacturers offering products with different dosages. Manufacturers have established strong collaborations with distribution chain partners to strengthen the supply chain of laxative products for adult patients suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic conditions. This continuity of the supply chain is anticipated to keep the constipation-laxative market afloat throughout the duration of the pandemic.  

Analyst’s Viewpoint:

“Rising adoption of sedentary lifestyles has led to a reduced intake of water by individuals in the wake of reduced physical activity. As a consequence, incidence of constipation has increased in both the developing and developed countries. This is expected to burgeon market prospects in the future.”

Global Constipation Laxative Market: Report Scope:
The recent study undertaken by Fact.MR on the global constipation laxative market offers a decade-long forecast ranging from 2020 to 2030 and a historical analysis from 2015 to 2020. The report explicates on vital dynamics such as the drivers, opportunities and restraints impacting future growth of the market. The market has been analyzed in detail based on the following segments: Mode of Mechanism, Route of Administration and Distribution Channel.

A regional landscape has also been mapped, providing a region-wise analysis of the abovementioned segments. Regional profiling has been done based on the following regions: North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa. Towards the end of the report, a competitive landscape highlighting key players’ revenue and market share, product launches, key collaborations and mergers and acquisitions has been provided. In addition, a SWOT analysis of each players has been incorporated to provide a realistic outlook.

Global Constipation Laxative Market – Scope of the Report

The global constipation laxative market is anticipated to witness a notable upsurge during the forecast period 2020 to 2030, conferring to a new Fact.MR study. The study promotes crucial trends that are presently determining the growth of constipation laxative market. This newly published and perceptive report sheds light on vital dynamics, which are likely to convert the future of constipation laxative market, in turn generating worthwhile opportunities for key companies as well as evolving players who are interested in the manufacturing of constipation laxative.

Constipation laxative market study is a detailed market intellect on key revenue progression factors, challenges, industry trends, and opportunities, which will eventually influence the growth of constipation laxative market. The report primarily conveys a summary of the constipation laxative market, considering present and upcoming constipation laxative industry scenarios, to reveal striking sides relating to the acceptance of constipation laxative across prominent regional markets.

A detailed assessment on few of the constipation laxative raw material suppliers accessible in the report allows the report readers to obtain detailed findings that have resulted from constipation laxative supply chain analysis, business execution, and value chain analysis across the regional markets incorporated in the report. A list of prominent companies functioning within the constipation laxative market provided in the report enhances reliability of this ample research study.

Constipation Laxative Market: Report Summary

Study offers a comprehensive overview on diverse features that are inducing demand, revenue generation and sales in constipation laxative market across the globe.

A comprehensive estimate on constipation laxative market has also been made accessible by the experts, who have considered the market estimates on the basis of a likely scenario, an optimistic scenario, and a conservative scenario regarding sales of constipation laxative during the forecast period. Analysis and estimation of price point comparison by region and by product with the global average price has been included in this study.

Constipation Laxative Market: Segmentation

FactMR’s study has done the segmentation of constipation laxative market on the basis of mode of mechanism, route of administration, distribution channel, across five regions.

Mode of Mechanism

Route of Administration

Distribution Channel

Regions

Lubricant

Bulk Forming

Emollient(Stool softeners)

Stimulant

Saline Laxatives

Hyperosmotic

Others

Oral

Rectal

 

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Online Pharmacies 

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East & Africa


Constipation laxative Market: Analysis on Market Size Evaluation

Predictions of constipation laxative market, encompassing current as well as forthcoming projected values estimate and analysis on region-wise demand trends and price index have been assimilated in the report.

Market estimates at the regional and global scale for constipation laxative are available in terms of value “US$ Mn” and volume “Mn Sq. Meters”. A Y-o-Y growth contrast on prominent constipation laxative market segments, along with the market attractiveness valuation computes understandings brought in the report. Metrics mentioned above are also followed based on constipation laxative applications where constipation laxative witness a steady demand.

Constipation Laxative Market: Scrutinized Assessment on Regional Segments

Weighted sections have been elaborated in the report on constipation laxative market, which delivers projection on the regional markets. These chapters brighten the regional macros (political economic, and business environment outlook), which are expected to have a significant impact on the growth of constipation laxative market during period of forecast.

Country-specific valuation on demand for constipation laxative has been offered for each regional market, along with the market scope estimate and forecast, price index, price point assessment, and impact analysis of dynamics of prominent regions and countries. For all regional markets Y-o-Y growth estimates have also been incorporated in the report.

Constipation Laxative Market: In-depth Analysis on Competitive Landscape

The report ends with a section on the competition scenario of constipation laxative market, along with the profiles of major companies contributing to the market expansion. Essential and up-to-date data as well as information correlated to the market performers, who principally engage in the production and supply of constipation laxative, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to plan preemptive steps to advance their businesses.

Company profiles have been shared with report, which exerts essentials such as product portfolio, along with an all-inclusive SWOT analysis on each player recognized along with the company policies identification and analysis. The company presence mapped and presented through the matrix for all the prominent players of the market functioning in constipation laxative market offers readers with actionable intellect, which helps in thoughtfully presenting the market status, and making decisive predictions on the competition levels in Constipation laxative market. Major companies operating in constipation laxative market are CERAMICHE ATLAS CONCORDE S.P.A, Cersanit SA, Florim Ceramiche S.P.A, Grupo Lamosa SAB de CV, Johnson Tiles and others.

Impact of Covid-19 on Constipation Laxative Market

The report includes a scenario based assessment of impact of Covid-19 across key regions for all four quarters of 2020. The report discusses the market forecast under optimistic, probabilistic and pessimistic scenario. Under the three scenarios, the demand loss and recovery has been illustrated and described through L-shaped and U-shaped recovery curves. Alongside, the Covid-19 impact has been benchmarked with previous crisis including sub-prime crisis, Eurozone crisis and SARS pandemic.

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Management Pyramid for Patients with Chronic Constipation

    4.2. Rome III Diagnostic Criteria for Adult

    4.3. Patient Demography

    4.4. Key Strategies Adopted by Companies Offering Constipation-Laxative

    4.5. Promotional Strategies

    Market Context

    1.1. Value Chain Analysis

    1.2. FDA Drug Approval Processes

    1.3. Europe Drug Approval Process

5. Market Background

    5.1. COVID19 Crisis Analysis

        5.1.1. Current COVID19 Statistics and Probable Future Impact

        5.1.2. Current GDP Projection and Probable Impact

        5.1.3. Current Economic Projection as compared to 2008 Economic analysis

        5.1.4. COVID19 and Impact Analysis

            5.1.4.1. Revenue By Mode of Mechanism

            5.1.4.2. Revenue By Distribution Channel

    5.2. Macro-Economic Factors

        5.2.1. Increase in Prevalence of Constipation 

        5.2.2. Burden of Chronic Constipation

    5.3. Forecast Factors - Relevance & Impact

        5.3.1. Rising Prevalence of Constipation in the Geriatric Population

        5.3.2. Rising Obese Cases

    5.4. Market Dynamics

        5.4.1. Drivers

        5.4.2. Restraints

        5.4.3. Trends

        5.4.4. Opportunity Analysis

6. Global Constipation-Laxative Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

    6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

    6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

        6.2.1. Y-o-Y Growth Trend Analysis

        6.2.2. Absolute $ Opportunity Analysis

7. Global Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030, By Mode of Mechanism 

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) By Mode of Mechanism , 2015-2019

    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mode of Mechanism , 2020-2030

        7.3.1. Bulk-forming

        7.3.2. Lubricant

        7.3.3. Emollient (Stool Softeners)

        7.3.4. Stimulant

        7.3.5. Saline Laxative

        7.3.6. Hyperosmotic

        7.3.7. Others

    7.4. Market Attractiveness Analysis By Mode of Mechanism 

8. Global Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030, By Route of Administration 

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) By Route of Administration, 2015-2019

    8.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Type , 2020-2030

        8.3.1. Oral

        8.3.2. Rectal 

    8.4. Market Attractiveness Analysis By Route of Administration

9. Global Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel 

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2015-2019

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2020-2030

        9.3.1. Hospital Pharmacies

        9.3.2. Retail Pharmacies

        9.3.3. Drug Stores

        9.3.4. Online Pharmacies

    9.4. Market Attractiveness Analysis By Distribution Channel

10. Global Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030, by Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2019

    10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2030

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. East Asia

        10.3.5. South Asia

        10.3.6. Oceania

        10.3.7. Middle East and Africa (MEA)

    10.4. Market Attractiveness Analysis By Region

11. North America Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2019

    11.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020-2030

        11.3.1.  By Country

            11.3.1.1.  U.S.

            11.3.1.2.  Canada

        11.3.2. By Mode of Mechanism 

        11.3.3. By Route of Administration

        11.3.4. By Distribution Channel

    11.4. Market Attractiveness Analysis

    11.5. Drivers and Restraints - Impact Analysis

12. Latin America Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 - 2019

    12.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020-2030

        12.3.1.  By Country

            12.3.1.1. Brazil

            12.3.1.2. Mexico

            12.3.1.3. Argentina

            12.3.1.4. Rest of Latin America

        12.3.2. By Mode of Mechanism 

        12.3.3. By Route of Administration

        12.3.4. By Distribution Channel

    12.4. Market Attractiveness Analysis

    12.5. Drivers and Restraints - Impact Analysis

13. Europe Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2019

    13.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy2020-2030

        13.3.1.  By Country

            13.3.1.1. Germany

            13.3.1.2. Italy

            13.3.1.3. France

            13.3.1.4. U.K.

            13.3.1.5. Spain

            13.3.1.6. BENELUX

            13.3.1.7. Russia

            13.3.1.8. Rest of Europe

        13.3.2. By Mode of Mechanism 

        13.3.3. By Route of Administration

        13.3.4. By Distribution Channel

    13.4. Market Attractiveness Analysis

    13.5. Drivers and Restraints - Impact Analysis

14. South Asia Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2019

    14.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy2020-2030

        14.3.1.  By Country

            14.3.1.1. India

            14.3.1.2. Thailand

            14.3.1.3. Indonesia

            14.3.1.4. Malaysia

            14.3.1.5. Rest of South Asia

        14.3.2. By Mode of Mechanism 

        14.3.3. By Route of Administration

        14.3.4. By Distribution Channel

    14.4. Market Attractiveness Analysis

    14.5. Drivers and Restraints - Impact Analysis

15. East Asia Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2019

    15.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020-2030

        15.3.1.  By Country

            15.3.1.1. China

            15.3.1.2. Japan

            15.3.1.3. South Korea

        15.3.2. By Mode of Mechanism 

        15.3.3. By Route of Administration

        15.3.4. By Distribution Channel

    15.4. Market Attractiveness Analysis

    15.5. Drivers and Restraints - Impact Analysis

16. Oceania Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2019

    16.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020-2030

        16.3.1.  By Country

            16.3.1.1. Australia

            16.3.1.2. New Zealand

        16.3.2. By Mode of Mechanism 

        16.3.3. By Route of Administration

        16.3.4. By Distribution Channel

    16.4. Market Attractiveness Analysis

    16.5. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2019

    17.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020-2030

        17.3.1.  By Country

            17.3.1.1. GCC Countries

            17.3.1.2. Turkey

            17.3.1.3. South Africa

            17.3.1.4. Rest of Middle East and Africa

        17.3.2. By Mode of Mechanism 

        17.3.3. By Route of Administration

        17.3.4. By Distribution Channel

    17.4. Market Attractiveness Analysis

    17.5. Drivers and Restraints - Impact Analysis

18. Key and Emerging Countries Constipation-Laxative Market Analysis 2015-2019 and Forecast 2020-2030

    18.1. U.S. Constipation-Laxative Market Analysis

        18.1.1. By Mode of Mechanism

        18.1.2. By Route of Administration

        18.1.3. By Distribution Channel

    18.2. Canada Constipation-Laxative Market Analysis

        18.2.1. By Mode of Mechanism 

        18.2.2. By Route of Administration

        18.2.3. By Distribution Channel

    18.3. Mexico Constipation-Laxative Market Analysis

        18.3.1. By Mode of Mechanism 

        18.3.2. By Route of Administration

        18.3.3. By Distribution Channel

    18.4. U.K. Constipation-Laxative Market Analysis

        18.4.1. By Mode of Mechanism 

        18.4.2. By Route of Administration

        18.4.3. By Distribution Channel

    18.5. Germany Constipation-Laxative Market Analysis

        18.5.1. By Mode of Mechanism 

        18.5.2. By Route of Administration

        18.5.3. By Distribution Channel

    18.6. France Constipation-Laxative Market Analysis

        18.6.1. By Mode of Mechanism 

        18.6.2. By Route of Administration

        18.6.3. By Distribution Channel

    18.7. Italy Constipation-Laxative Market Analysis

        18.7.1. By Mode of Mechanism 

        18.7.2. By Route of Administration

        18.7.3. By Distribution Channel

    18.8. Spain Constipation-Laxative Market Analysis

        18.8.1. By Mode of Mechanism 

        18.8.2. By Route of Administration

        18.8.3. By Distribution Channel

    18.9. BENELUX Constipation-Laxative Market Analysis

        18.9.1. By Mode of Mechanism 

        18.9.2. By Route of Administration

        18.9.3. By Distribution Channel

    18.10. Russia Constipation-Laxative Market Analysis

        18.10.1. By Mode of Mechanism 

        18.10.2. By Route of Administration

        18.10.3. By Distribution Channel

    18.11. Japan Constipation-Laxative Market Analysis

        18.11.1. By Mode of Mechanism 

        18.11.2. By Route of Administration

        18.11.3. By Distribution Channel

    18.12. South Korea Constipation-Laxative Market Analysis

        18.12.1. By Mode of Mechanism 

        18.12.2. By Route of Administration

        18.12.3. By Distribution Channel

    18.13. Australia Constipation-Laxative Market Analysis

        18.13.1. By Mode of Mechanism 

        18.13.2. By Route of Administration

        18.13.3. By Distribution Channel

    18.14. New Zealand Constipation-Laxative Market Analysis

        18.14.1. By Mode of Mechanism 

        18.14.2. By Route of Administration

        18.14.3. By Distribution Channel

    18.15. GCC Countries Constipation-Laxative Market Analysis

        18.15.1. By Mode of Mechanism 

        18.15.2. By Route of Administration

        18.15.3. By Distribution Channel

    18.16. Turkey Constipation-Laxative Market Analysis

        18.16.1. By Mode of Mechanism 

        18.16.2. By Route of Administration

        18.16.3. By Distribution Channel

    18.17. South Africa Constipation-Laxative Market Analysis

        18.17.1. By Route of Administration

        18.17.2. By Mode of Mechanism 

        18.17.3. By Route of Administration 

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies 

    19.2. Market Concentration

    19.3. Market Share Analysis of Top Players

    19.4. Market Presence Analysis

            19.4.1.1. Regional footprint of Players

            19.4.1.2. Method foot print by Players

            19.4.1.3. Channel Foot Print by Players

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive 

        20.3.1. Bayer AG

            20.3.1.1. Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Profitability by Market Segments (Drugs/Channel/Region)

            20.3.1.4. Sales Footprint

            20.3.1.5. Strategy Overview

                20.3.1.5.1. Marketing Strategy

                20.3.1.5.2. Product Strategy

                20.3.1.5.3. Channel Strategy

        20.3.2. Abbott Laboratories

            20.3.2.1. Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Profitability by Market Segments (Drugs/Channel/Region)

            20.3.2.4. Sales Footprint

            20.3.2.5. Strategy Overview

                20.3.2.5.1. Marketing Strategy

                20.3.2.5.2. Product Strategy

                20.3.2.5.3. Channel Strategy

        20.3.3. Sanofi S.A

            20.3.3.1. Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Profitability by Market Segments (Drugs/Channel/Region)

            20.3.3.4. Sales Footprint

            20.3.3.5. Strategy Overview

                20.3.3.5.1. Marketing Strategy

                20.3.3.5.2. Product Strategy

                20.3.3.5.3. Channel Strategy

        20.3.4. GlaxoSmithKline Pharmaceuticals Ltd

            20.3.4.1. Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Profitability by Market Segments (Drugs/Channel/Region)

            20.3.4.4. Sales Footprint

            20.3.4.5. Strategy Overview

                20.3.4.5.1. Marketing Strategy

                20.3.4.5.2. Product Strategy

                20.3.4.5.3. Channel Strategy

        20.3.5. Mallinckrodt Pharmaceuticals

            20.3.5.1. Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Profitability by Market Segments (Drugs/Channel/Region)

            20.3.5.4. Sales Footprint

            20.3.5.5. Strategy Overview

                20.3.5.5.1. Marketing Strategy

                20.3.5.5.2. Product Strategy

                20.3.5.5.3. Channel Strategy

        20.3.6. Sebela Pharmaceuticals

            20.3.6.1. Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Profitability by Market Segments (Drugs/Channel/Region)

            20.3.6.4. Sales Footprint

            20.3.6.5. Strategy Overview

                20.3.6.5.1. Marketing Strategy

                20.3.6.5.2. Product Strategy

                20.3.6.5.3. Channel Strategy

        20.3.7. Procter & Gamble Company.

            20.3.7.1. Overview

            20.3.7.2. Product Portfolio

            20.3.7.3. Profitability by Market Segments (Drugs/Channel/Region)

            20.3.7.4. Sales Footprint

            20.3.7.5. Strategy Overview

                20.3.7.5.1. Marketing Strategy

                20.3.7.5.2. Product Strategy

                20.3.7.5.3. Channel Strategy

        20.3.8. Takeda Pharmaceutical Company Limited 

            20.3.8.1. Overview

            20.3.8.2. Product Portfolio

            20.3.8.3. Profitability by Market Segments (Drugs/Channel/Region)

            20.3.8.4. Sales Footprint

            20.3.8.5. Strategy Overview

                20.3.8.5.1. Marketing Strategy

                20.3.8.5.2. Product Strategy

                20.3.8.5.3. Channel Strategy

        20.3.9. Purdue Pharmaceuticals L.P

            20.3.9.1. Overview

            20.3.9.2. Product Portfolio

            20.3.9.3. Profitability by Market Segments (Drugs/Channel/Region)

            20.3.9.4. Sales Footprint

            20.3.9.5. Strategy Overview

                20.3.9.5.1. Marketing Strategy

                20.3.9.5.2. Product Strategy

                20.3.9.5.3. Channel Strategy

        20.3.10. Sun Pharmaceutical Industries Ltd

            20.3.10.1. Overview

            20.3.10.2. Product Portfolio

            20.3.10.3. Profitability by Market Segments (Drugs/Channel/Region)

            20.3.10.4. Sales Footprint

            20.3.10.5. Strategy Overview

                20.3.10.5.1. Marketing Strategy

                20.3.10.5.2. Product Strategy

                20.3.10.5.3. Channel Strategy

        20.3.11. Dr. Reddy’s Laboratories Ltd.

            20.3.11.1. Overview

            20.3.11.2. Product Portfolio

            20.3.11.3. Profitability by Market Segments (Drugs/Channel/Region)

            20.3.11.4. Sales Footprint

            20.3.11.5. Strategy Overview

                20.3.11.5.1. Marketing Strategy

                20.3.11.5.2. Product Strategy

                20.3.11.5.3. Channel Strategy

        20.3.12. Cipla Ltd

            20.3.12.1. Overview

            20.3.12.2. Product Portfolio

            20.3.12.3. Profitability by Market Segments (Drugs/Channel/Region)

            20.3.12.4. Sales Footprint

            20.3.12.5. Strategy Overview

                20.3.12.5.1. Marketing Strategy

                20.3.12.5.2. Product Strategy

                20.3.12.5.3. Channel Strategy

        20.3.13. Mankind Pharma Ltd

            20.3.13.1. Overview

            20.3.13.2. Product Portfolio

            20.3.13.3. Profitability by Market Segments (Drugs/Channel/Region)

            20.3.13.4. Sales Footprint

            20.3.13.5. Strategy Overview

                20.3.13.5.1. Marketing Strategy

                20.3.13.5.2. Product Strategy

                20.3.13.5.3. Channel Strategy

        20.3.14. Beutlich Pharmaceuticals, LLC

            20.3.14.1. Overview

            20.3.14.2. Product Portfolio

            20.3.14.3. Profitability by Market Segments (Drugs/Channel/Region)

            20.3.14.4. Sales Footprint

            20.3.14.5. Strategy Overview

                20.3.14.5.1. Marketing Strategy

                20.3.14.5.2. Product Strategy

                20.3.14.5.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Constipation Laxative Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2030